Page last updated: 2024-08-26

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Lung Diseases

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Lung Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eger, EI; Ferrell, LD; Gonsowski, CT; Kerschmann, RL; Laster, MJ1

Other Studies

1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Lung Diseases

ArticleYear
Toxicity of compound A in rats. Effect of increasing duration of administration.
    Anesthesiology, 1994, Volume: 80, Issue:3

    Topics: Anesthetics; Animals; Body Weight; Cell Division; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethers; Hydrocarbons, Fluorinated; Immunohistochemistry; Kidney Diseases; Lethal Dose 50; Lung Diseases; Male; Methyl Ethers; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Pulmonary Edema; Rats; Rats, Wistar; Regeneration; Sevoflurane; Time Factors

1994